Tecrapharm cooperates with biopharmaceutical companies for their transition period to secure the supply of crucial drugs, if they have decided to not follow their commercialization in certain markets anymore. In some cases, Tecrapharm takes over the product as the Market Authorisation Holder depending on the market and territory. The process is an enormous benefit both for the manufacturer as well as for the patients as the access to the medicine is maintained.
Tecrapharm actively approaches biopharmaceutical companies to acquire their assets or asset rights, which are no more of strategic value for the asset owner regardless of the therapeutical field and indication.
With our unique global footprint, we broaden the coverage of acquired products by supporting them with different regulatory registration as well as market access pathways-